Back to Agenda
Clinical Trial Registration and Results Disclosure: Impact on Medical Writing and Publications
Session Chair(s)
Barbara Godlew, RN
Associate Consultant, Scientific Communications, GSC-Bio-Medicines
Eli Lilly and Company, United States
Clinical trial disclosure provides wide publicly available access to clinical trial protocols and trial results. Recent industry developments to share data and evolving journal requirements for data disclosure with manuscript submission affect medical writing and clinical/scientific manuscripts. This session will explore best practices in coordinating clinical trial disclosure, medical writing, and publications.
Speaker(s)
Faculty
Barbara Godlew, RN
Eli Lilly and Company, United States
Associate Consultant, Scientific Communications, GSC-Bio-Medicines
Faculty
Marla Jo Brickman, PhD
Pfizer Inc, United States
Senior Director - Clinical Data Transparency/Compassionate Access Lead
Faculty
Maureen Garrity
Astellas Pharma Inc., United States
Have an account?